Immunohistochemical Expression of Glutathione Peroxidase-2 (Gpx-2) and Its Clinical Relevance in Colon Adenocarcinoma Patients.
5-year survival
colon adenocarcinoma
glutathione peroxidase
immunogold labelling
immunohistochemistry
oxidative stress
prognostic marker
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
27 Sep 2023
27 Sep 2023
Historique:
received:
05
08
2023
revised:
14
09
2023
accepted:
19
09
2023
medline:
1
11
2023
pubmed:
14
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
Glutathione peroxidase 2 (Gpx-2) is a selenoenzyme with antioxidant capabilities that may play a role in cancer development. Hence, we investigated the immunohistochemical expression of Gpx-2 protein in colon adenocarcinoma samples derived from patients with colon adenocarcinoma who did not receive any form of treatment prior to the surgical procedure. The associations between the immunohistochemical expression of Gpx-2 and clinical parameters were analysed using the Chi
Identifiants
pubmed: 37834097
pii: ijms241914650
doi: 10.3390/ijms241914650
pmc: PMC10572251
pii:
doi:
Substances chimiques
Glutathione Peroxidase
EC 1.11.1.9
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical University of Silesia
ID : PCN-1-181/N/1/I
Références
World J Urol. 2015 Nov;33(11):1777-89
pubmed: 25813210
Tumour Biol. 2017 Jun;39(6):1010428317700410
pubmed: 28635398
Proc Natl Acad Sci U S A. 2022 Feb 22;119(8):
pubmed: 35193955
J Cancer. 2021 May 5;12(13):3796-3808
pubmed: 34093788
J Biol Chem. 1993 Feb 5;268(4):2571-6
pubmed: 8428933
Gut. 2017 Apr;66(4):683-691
pubmed: 26818619
Oncol Rep. 2022 Dec;48(6):
pubmed: 36222298
J Cell Physiol. 2020 Nov;235(11):7780-7790
pubmed: 31774184
FASEB Bioadv. 2023 Apr 08;5(6):233-250
pubmed: 37287867
Cancer Lett. 2008 Feb 8;259(2):218-30
pubmed: 18054426
PLoS One. 2015 Nov 16;10(11):e0143067
pubmed: 26571301
Pathologe. 1987 May;8(3):138-40
pubmed: 3303008
Biochim Biophys Acta. 2009 Nov;1790(11):1555-68
pubmed: 19289149
J Adv Res. 2023 Feb;44:173-183
pubmed: 36725188
Int J Biochem Cell Biol. 2023 Jan;154:106346
pubmed: 36538984
Cancer Res. 2007 Dec 1;67(23):11353-8
pubmed: 18056462
Int J Mol Sci. 2023 Apr 19;24(8):
pubmed: 37108670
Cancer Res. 2014 Nov 15;74(22):6717-30
pubmed: 25261240
Biomolecules. 2019 Nov 13;9(11):
pubmed: 31766246
BMC Cancer. 2016 Jul 07;16:410
pubmed: 27388201
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Toxicol Environ Health A. 2005 May 14;68(9):703-18
pubmed: 16020198
FEBS J. 2008 Aug;275(15):3959-70
pubmed: 18616466
Cells. 2022 Jun 10;11(12):
pubmed: 35741021
Biochim Biophys Acta. 2013 May;1830(5):3289-303
pubmed: 23201771
Clin Gastroenterol Hepatol. 2021 May;19(5):955-966.e61
pubmed: 32088300
Int J Mol Sci. 2018 Oct 25;19(11):
pubmed: 30366446
Toxicology. 2013 Sep 15;311(3):115-23
pubmed: 23867582
BMC Cancer. 2020 Apr 15;20(1):305
pubmed: 32293338
Biochem Biophys Res Commun. 2022 Dec 10;633:17-19
pubmed: 36344150
Tumour Biol. 2017 Jun;39(6):1010428317701443
pubmed: 28631563
Int J Mol Sci. 2018 Aug 30;19(9):
pubmed: 30200215
Antioxidants (Basel). 2021 Nov 19;10(11):
pubmed: 34829712
Int J Mol Sci. 2023 Jan 23;24(3):
pubmed: 36768598
Free Radic Res. 2001 Dec;35(6):655-63
pubmed: 11811519
Oncotarget. 2018 Mar 23;9(22):15847-15859
pubmed: 29662611
Oncogene. 1997 Feb 13;14(6):629-40
pubmed: 9038370
Carcinogenesis. 2014 Sep;35(9):1962-7
pubmed: 24562575
Free Radic Biol Med. 2022 Aug 1;188:419-433
pubmed: 35803440